Skip to main content

and
  1. No Access

    Article

    Evolutionary characterization of lung adenocarcinoma morphology in TRACERx

    Lung adenocarcinomas (LUADs) display a broad histological spectrum from low-grade lepidic tumors through to mid-grade acinar and papillary and high-grade solid, cribriform and micropapillary tumors. How morpho...

    Takahiro Karasaki, David A. Moore, Selvaraju Veeriah in Nature Medicine (2023)

  2. Article

    Publisher Correction: A clonal expression biomarker associates with lung cancer mortality

    An amendment to this paper has been published and can be accessed via a link at the top of the paper.

    Dhruva Biswas, Nicolai J. Birkbak, Rachel Rosenthal, Crispin T. Hiley in Nature Medicine (2020)

  3. Article

    Publisher Correction: Pulmonary venous circulating tumor cell dissemination before tumor resection and disease relapse

    An amendment to this paper has been published and can be accessed via a link at the top of the paper.

    Francesca Chemi, Dominic G. Rothwell, Nicholas McGranahan, Sakshi Gulati in Nature Medicine (2020)

  4. No Access

    Article

    A clonal expression biomarker associates with lung cancer mortality

    An aim of molecular biomarkers is to stratify patients with cancer into disease subtypes predictive of outcome, improving diagnostic precision beyond clinical descriptors such as tumor stage1. Transcriptomic intr...

    Dhruva Biswas, Nicolai J. Birkbak, Rachel Rosenthal, Crispin T. Hiley in Nature Medicine (2019)

  5. No Access

    Article

    Pulmonary venous circulating tumor cell dissemination before tumor resection and disease relapse

    Approximately 50% of patients with early-stage non-small-cell lung cancer (NSCLC) who undergo surgery with curative intent will relapse within 5 years1,2. Detection of circulating tumor cells (CTCs) at the time o...

    Francesca Chemi, Dominic G. Rothwell, Nicholas McGranahan, Sakshi Gulati in Nature Medicine (2019)